A wide spectrum of clinical manifestations has become a hallmark of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the …

Antibody responses to viral infections are sustained for decades by long-lived plasma cells (LLPCs).
However, LLPCs have yet to be characterized in humans. Here we used CD19, …

Severe SARS-CoV-2 infection 1 has been associated with highly inflammatory immune
activation since the earliest days of the COVID-19 pandemic 2 , 3 , 4 – 5 . More recently, these …

Upon vaccination, B cells differentiate into antibody secreting cells (ASCs) that migrate via the
circulation to tissues. The kinetics of this response and the relationship of circulating ASCs …

Human antibody-secreting cells (ASC) in peripheral blood are found after vaccination or
infection but rapidly apoptose unless they migrate to the bone marrow (BM). Yet, elements of the …

Wide heterogeneity of disease course ranging from asymptomatic spread 1 , 2 to respiratory
failure and death 3 , 4 has become a hallmark of the SARS-CoV-2 (COVID-19) pandemic. …

The rise in influenza-specific neutralizing antibody levels is proceeded by a burst of antigen-specific
antibody secreting cells (ASC) or plasmablasts identified in peripheral blood …

An emerging feature of COVID-19 is the identification of autoreactivity in patients with severe
disease that may contribute to disease pathology, however the origin and resolution of …

Human antibody-secreting cells (ASCs) triggered by immunization are globally recognized
as CD19 lo CD38 hi CD27 hi. Yet, different vaccines give rise to antibody responses of …

Immunoglobulin (Ig) E is central to the pathogenesis of allergic conditions, including allergic
fungal rhinosinusitis. However, little is known about IgE antibody secreting cells (ASCs). We …